___
A new article published by Vox Sanguinis (Early Edition) shares dramatic information about Jehovah's Witnesses and a common disorder known as anemia.[1] In particular this article addresses outcomes related to severe anemia as depicted below.
This article is a retrospective observational study comparing patients treated with allogeneic red blood cell (ARBC) transfusion against Jehovah’s Witness patients who had refused allogeneic red cells transfusion.
This study reviewed data from 4 hospitals in New Zealand for the years of 1998-2007.
A total of 10,786 admissions were found for 3,529 individual Witness patients. Patients included in this review were 15-years-old or older, and presented with hemoglobin concentration at or less than 80 grams per liter (80 g/l). 103 of the Witness patients met the eligibility profile and were included in the study.
Patients who were treated with allogeneic red cells transfusion were randomly drawn in a 1:1 ratio from the same diagnosis group from the same hospitals and years.
Hence the study compared 103 Witness patients with 103 non-Witness patients with the difference being that one group received transfusion of allogeneic red cells and the other received alternative care with products acceptable under Watchtower’s blood doctrine.
The result
A new article published by Vox Sanguinis (Early Edition) shares dramatic information about Jehovah's Witnesses and a common disorder known as anemia.[1] In particular this article addresses outcomes related to severe anemia as depicted below.
This article is a retrospective observational study comparing patients treated with allogeneic red blood cell (ARBC) transfusion against Jehovah’s Witness patients who had refused allogeneic red cells transfusion.
This study reviewed data from 4 hospitals in New Zealand for the years of 1998-2007.
A total of 10,786 admissions were found for 3,529 individual Witness patients. Patients included in this review were 15-years-old or older, and presented with hemoglobin concentration at or less than 80 grams per liter (80 g/l). 103 of the Witness patients met the eligibility profile and were included in the study.
Patients who were treated with allogeneic red cells transfusion were randomly drawn in a 1:1 ratio from the same diagnosis group from the same hospitals and years.
Hence the study compared 103 Witness patients with 103 non-Witness patients with the difference being that one group received transfusion of allogeneic red cells and the other received alternative care with products acceptable under Watchtower’s blood doctrine.
The result
A 10 times greater incident of death. 10 times!
How long is Watchtower's Governing Body going to let this carnage continue?[2] How long?
Marvin Shilmer
______________
References
1. Beliaev et al, Clinical benefits and cost-effectiveness of allogeneic red-blood-cell transfusion in severe symptomatic anaemia, Vox Sanguinis (Early View, Online Version of Record published before inclusion in an issue), Article first published online: December 13, 2011.
2. For more on mortality experienced by Jehovah’s Witnesses related to Watchtower’s blood doctrine see the articles:
● More than 50,000 dead
● Stark Reality Facing Jehovah’s Witnesses on Blood
● Watchtower doctrine that kills Jehovah’s Witnesses
___
0 comments:
Post a Comment